Age, median (range), years |
60 (27-88) |
Tumor size*, median (range), mm |
35 (10-145) |
FIGO tumor stage, n (%) |
|
I |
112 (85) |
II |
5 (4) |
III |
13 (10) |
IV |
2 (1) |
Any myometrial invasion, n (%) |
|
Yes |
95 (72) |
No |
37 (28) |
Myometrial invasion ≥50%, n (%) |
|
Yes |
30 (23) |
No |
102 (77) |
Lymphovascular space invasion, n (%) |
|
Yes |
30 (23) |
No |
102 (77) |
Metastasis to pelvic lymph nodes, n (%) |
|
Yes |
11 (8) |
No |
77 (58) |
Lymph node dissection not performed |
44 (33) |
Metastasis to para-aortic lymph nodes, n (%) |
|
Yes |
5 (4) |
No |
46 (35) |
Lymph node dissection not performed |
81 (61) |
PTEN immunohistochemistry |
|
Positive |
65 (49) |
Heterogeneous |
8 (6) |
Negative |
59 (45) |